Problems in pathologic staging of lung cancer

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 3, 2006, Pages 292-302

  Marchevsky, Alberto M ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; HUMAN; LETHALITY; LUNG CANCER; LUNG TUMOR; LYMPH NODE METASTASIS; MEDICAL SOCIETY; NOMENCLATURE; PATHOLOGY; PLEURA METASTASIS; PREDICTION; PROGNOSIS; THORAX SURGERY; TREATMENT PLANNING; TUMOR VOLUME; UNITED STATES;

HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; PATHOLOGY, SURGICAL; PRACTICE GUIDELINES; PROBLEM SOLVING; PROGNOSIS; SOCIETIES, MEDICAL; UNITED STATES;

EID: 33645002408     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (92)

1. American Cancer Society: Cancer Statistics for 2005. Atlanta, Ga: American Cancer Society; 2005.
2. Doll R. Risk from tobacco and potentials for health gain. Int J Tuberc Lung Dis. 1999;3:90-99.
3. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ. 1994;309:901-911.
4. Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;5;321:323-1329.
5. Boffetta P. Involuntary smoking and lung cancer. Scand J Work Environ Health. 2002;28(suppl 2):30-40.
6. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC, eds. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004.
7. World Health Organization Classification of Tumours; vol 10.
8. Pathak AK, Bhutani M, Mohan A, Guleria R, Bal S, Kochupillai V. Non small cell lung cancer (NSCLC): current status and future prospects. Indian J Chest Dis Allied Sci. 2004;46:191-203.
9. Stupp R, Monnerat C, Turrisi AT III, Perry MC, Leyvraz S. Small cell lung cancer: state of the art and future perspectives. Lung Cancer. 2004;45:105-117.
10. Dexter EU, Jahangir N, Kohman LJ. Resection for lung cancer in the elderly patient. Thorac Surg Clin. 2004;14:163-171.
11. Deslauriers J, Gregoire J, Jacques LF, Piraux M. Sleeve pneumonectomy. Thorac Surg Clin. 2004;14:183-190.
12. Waddell TK, Shepherd FA. Should aggressive surgery ever be part of the management of small cell lung cancer? Thorac Surg Clin. 2004;14:271-281.
13. Mountain CF. The international system for staging lung cancer. Semin Surg Oncol. 2000;18:106-115.
14. Rami-Porta R, Lopez-Encuentra A, Duque-Medina JL. Caution! The latest AJCC's rules for lung cancer classification differ from the latest UICC's. Lung Cancer. 2004;43:361-362.
15. Mountain CF. Staging classification of lung cancer: a critical evaluation. Clin Chest Med. 2002;23:103-121.
16. Nicholson SA, Beasley MB, Brambilla E, et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol. 2002;26:1184-1197.
17. Bradley JD, Dehdashti F, Mintun MA, Govindan R, Trinkaus K, Siegel BA. Positron emission tomography in limited-stage small-cell lung cancer: a prospective study. J Clin Oncol. 2004;15;22:3248-3254.
18. Murray N, Sheehan F. Limited stage small cell lung cancer. Curr Treat Options Oncol. 2001;2:63-70.
19. Finke NM, Aubry MC, Tazelaar HD, et al. Autopsy results after surgery for non-small cell lung cancer. Mayo Clin Proc. 2004;79:1409-1414.
20. Marchevsky AM, Gal AA, Shah S, Koss MN. Morphometry confirms the presence of considerable nuclear size overlap between "small cells& and &large cells& in high-grade pulmonary neuroendocrine neoplasms. Am J Clin Pathol. 2001;116:466-472.
21. Marchevsky AM, Chuang MT, Teirstein AS, Nieburgs HE, Kleinerman J. Problems in the diagnosis of small cell carcinoma of the lungs by fiberoptic bronchoscopy. Cancer Detect Prev. 1984;7:253-260.
22. Marchevsky AM. Neuroendocrine tumors of the lung. Pathology (Phila). 1996;4:103-123.
23. Travis WD, Gal AA, Colby TV, Klimstra DS, Falk R, Koss MN. Reproducibility of neuroendocrine lung tumor classification. Hum Pathol. 1998;29:272-279.
24. Greene FL, Page DL, Fleming ID, et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
25. Sihoe AD, Yim AP. Lung cancer staging. J Surg Res. 2004;117:92-106.
26. Gal AA, Marchevsky AM, Travis WD. Updated protocol for the examination of specimens from patients with carcinoma of the lung. Arch Pathol Lab Med. 2003;127:1304-1313.
27. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9:633-643.
28. Ukena D, Hellwig D. Value of FDC PET in the management of NSCLC. Lung Cancer. 2004;45(suppl 2):S75-S78.
29. Cerfolio RJ, Ojha B, Bryant AS, Raghuveer V, Mountz JM, Bartolucci AA. The accuracy of integrated PET-CT compared with dedicated pet alone for the staging of patients with nonsmall cell lung cancer. Ann Thorac Surg. 2004;78: 1017-1023.
30. Kent MS, Port JL, Altorki NK. Current state of imaging for lung cancer staging. Thorac Surg Clin. 2004;14:1-13.
31. Mountain CF. Staging classification of lung cancer: a critical evaluation. Clin Chest Med. 2002;23:103-121.
32. Nesbitt JC, Putnam JB Jr, Walsh CL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995;60:466-472.
33. Alam N, Shepherd FA, Winton T, et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancers; sn analysis of National Cancer Institute of Canada and intergroup trial JBR.10 and a review of the literature. Lung Cancer. 2005;47:385-394.
34. Waller D, Peake MD, Stephens RJ, et al. Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg. 2004;26:173-182.
35. Buyukcelik A, Utkan C, Yalcin B. Adjuvant chemotherapy for lung cancer. N Engl J Med. 2004;350:1681-1683.
36. Ikhlaque N, Baumann MA. Adjuvant chemotherapy for lung cancer. N Engl J Med. 2004;15;350:1681-1683.
37. Fiegl M, Massoner A, Haun M, et al. Sensitive detection of tumour cells in effusions by combining cytology and fluorescence in situ hybridisation (FISH). Br J Cancer. 2004;2;91:558-563.
38. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg. 2004;127:1574-1578.
39. Osaki T, Nagashima A, Yoshimatsu T, Yamada S, Yasumoto K. Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. Ann Thorac Surg. 2004;77:1769-1773.
40. Lim E, Ali A, Theodorou P, Nicholson AG, Ladas C, Goldstraw P. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:1113-1118.
41. D'Amico TA. Value of intraoperative pleural lavage in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:947-948.
42. Shimizu K, Yoshida J, Nagai K, et al. Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment. J Thorac Cardiovasc Surg. 2004;127:1574-1578.
43. Kang JH, Kim KD, Chung KY. Prognostic value of visceral pleura invasion in non-small cell lung cancer. Eur J Cardlothorac Surg. 2003;23:865-869.
44. Saito Y, Yamakawa Y, Kiriyama M, et al. Diagnosis of visceral pleural invasion by lung cancer using intraoperative touch cytology. Ann Thorac Surg. 2002;73:1552-1556.
45. Manac'h D, Riquet M, Medioni J, Le Pimpec-Barthes F, Dujon A, Danel C. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor. Ann Thorac Surg. 2001;71:1088-1093.
46. Goldstraw P, Lim E. Value of intraoperative pleural lavage in staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;128:331.
47. Lim E, Ali A, Theodorou P, Nicholson AG, Ladas G, Goldstraw P. Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;127:1113-1118.
48. Matsuoka H, Nishio W, Okada M, Sakamoto T, Yoshimura M, Tsubota N. Resection of chest wall invasion in patients with non-small cell lung cancer. Eur J Cardiothorac Surg. 2004;26:1200-1204.
49. Burkhart HM, Allen MS, Nichols FC.III, et al. Results of en bloc resection for bronchogenic carcinoma with chest wall invasion. J Thorac Cardiovasc Surg. 2002;123:670-675.
50. Lin J, Iannettoni MD. The role of thoracoscopy in the management of lung cancer. Surg Oncol. 2003;12:195-200.
51. Roviaro GC, Varoli F, Vergani C, Maciocco M. State of the art in thoracoscopic surgery: a personal experience of 2000 videothoracoscopic procedures and an overview of the literature. Surg Endosc. 2002;16:881-892.
52. Sebastian-Quetglas F, Molins L, Baldo X, Buitrago J, Vidal C. Clinical value of video-assisted thoracoscopy for preoperative staging of non-small cell lung cancer: a prospective study of 105 patients. Lung Cancer. 2003;42:297-301.
53. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70:606-612.
54. Tan D, Li Q, Deeb C, et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-through-put tissue microarray and immunohistochemistry study. Hum Pathol. 2003;34: 597-604.
55. Churg A, Colby TV, Cagle P, et al. The separation of benign and malignant mesothelial proliferations. Am J Surg Pathol. 2000;24:1183-1200.
56. Fernando HC, Sasatomi E, Christie NA, et al. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study. J Thorac Cardiovasc Surg. 2004;127: 87-91.
57. Huang J, Behrens C, Wistuba I, Cazdar AF, Jagirdar J. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001;5:321-329.
58. Nakata M, Sawada S, Yamashita M, et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann Thorac Surg. 2004;78:1194-1199.
59. Motta C. Evolution and prognostic accuracy of staging system for NSCLC. Lung Cancer. 2003;42(suppl 2):S3-S4.
60. Maygarden SJ, Detterbeck FC, Funkhouser WK. Bronchial margins in lung cancer resection specimens: utility of frozen section and gross evaluation. Mod Pathol. 2004;17:1080-1086.
61. Lequaglie C, Conti B, Brega Massone PP, Ciudice C. Unsuspected residual disease at the resection margin after surgery for lung cancer: fate of patients after long-term follow-up. Eur J Cardiothorac Surg. 2003;23:229-232.
62. Passlick B, Sitar I, Sienel W, Thetter O, Morresi-Hauf A. Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer. Ann Thorac Surg. 2001;72:1160-1164.
63. Soorae AS, Stevenson HM. Survival with residual tumor on the bronchial margin after resection for bronchogenic carcinoma. J Thorac Cardiovasc Surg. 1979;78:175-180.
64. Dilege S, Toker A, Tanju S, et al. Chest wall invasion in lung cancer patients. Acta Chir Belg. 2003;103:396-400.
65. Doddoli C, D'Journo B, Le Pimpec-Barthes F, et al. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies. Ann Thorac Surg. 2005;80:2032-2040.
66. Beltrami V, Bezzi M, Illuminati G, et al. Surgical treatment of T3 lung cancer invading the chest wall. Chir Ital. 1999;51:417-420.
67. Higashiyama M, Kodama K, Takami K, Higaki N, Nakayama T, Yokouchi H. Intraoperative lavage cytologic analysis of surgical margins in patients undergoing limited surgery for lung cancer. J Thorac Cardiovasc Surg. 2003;125:101-107.
68. Sawabata N, Matsumura A, Ohota M, et al. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg. 2002; 74:1953-1957.
69. Mahesh B, Forrester-Wood C, Yunus A, et al. Value of wide-margin wedge resection for solitary pulmonary nodule: a single center experience. Eur J Cardiothorac Surg. 2004;26:474-479.
70. Hofmann HS, Taege C, Lautenschlager C, Neef H, Silber RE. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer. Eur J Cardiothorac Surg. 2002;21:606-610.
71. Goldstein NS, Ferkowicz M, Kestin L, Chmielewski GW, Welsh RJ. Wedge resection margin distances and residual adenocarcinoma in lobectomy specimens. Am J Clin Pathol. 2003;120:720-724.
72. Rigau V, Molina TJ, Chaffaud C, et al. Blood vessel invasion in resected non small cell lung carcinomas is predictive of metastatic occurrence. Lung Cancer. 2002;38:169-176.
73. Kessler R, Gasser B, Massard C, et al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann Thorac Surg. 1996; 62:1489-1493.
74. Goldstein NS, Mani A, Chmielewski C, Welsh R, Pursel S. Prognostic factors in T1 N0 M0 adenocarcinomas and bronchioloalveolar carcinomas of the lung. Am J Clin Pathol. 1999;112:391-402.
75. Faries MB, Bleicher RJ, Ye X, Essner R, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms. Arch Surg. 2004;139:870-876.
76. Rea F, Marulli G, Callegaro D, et al. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Lung Cancer. 2004;45:215-220.
77. Herth FJ. Mediastinal staging-the role of endobronchial and endo-oesophageal sonographic guided needle aspiration. Lung Cancer. 2004;45(suppl 2): S63-S67.
78. Oki M, Saka H, Kumazawa A, Sako C, Ando M, Watanabe A. The role of transcarinal needle aspiration in the diagnosis and staging of lung cancer: computed tomographic correlates of a positive result. Respiration. 2004;71:523-527.
79. Semik M, Netz B, Schmidt C, Scheld HH. Surgical exploration of the mediastinum: mediastinoscopy and intraoperative staging. Lung Cancer. 2004; 45(suppl 2):S55-S61.
80. Sihoe AD, Yim AP. Lung cancer staging. J Surg Res. 2004;117:92-106.
81. Okubo K, Kato T, Hara A, Yoshimi N, Takeda K, Iwao F. Imprint cytology for detecting metastasis of lung cancer in mediastinal lymph nodes. Ann Thorac Surg. 2004;78:1190-1193.
82. Marchevsky A. The mediastinum. In: Ranchod M, ed. Intraoperative Consultations in Surgical Pathology. Philadelphia, Pa: Belfus; 1996:339-348.
83. Lombard CM. Lung. In: Ranchod M, ed. Intraoperative Consultations in Surgical Pathology. Philadelphia, Pa: Belfus; 1996:321-338.
84. Bollen EC, Theunissen PH, van Duin CJ, Drenth BM, van Noord JA, Blijham CH. Clinical significance of intranodal and extranodal growth in lymph node metastases of non-small cell lung cancer. Scand J Thorac Cardiovasc Surg. 1994;28(3-4):97-102.
85. Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, McKenna RJ. The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell carcinoma of the lung. J Thorac Cardiovasc Surg. 2003; 126:551-557.
86. Pellise M, Castells A, Gines A, et al. Detection of lymph node micrometastases by gene promoter hypermethylation in samples obtained by endosonography-guided fine-needle aspiration biopsy. Clin Cancer Res. 2004;1:4444-4449.
87. Passlick B. Micrometastases in non-small cell lung cancer (NSCLC). Lung Cancer. 2001;34(suppl 3):S25-S29.
88. Nicholson AG, Graham AN, Pezzella F, Agneta G, Goldstraw P, Pastorino U. Does the use of immunohistochemistry to identify micrometastases provide useful information in the staging of node-negative non-small cell lung carcinomas? Lung Cancer. 1997;18:231-240.
89. Coello MC, Luketich JD, Litle VR, Godfrey TE. Prognostic significance of micrometastasis in non-small-cell lung cancer. Clin Lung Cancer. 2004;5:214-225.
90. D'Angelillo RM, Trodella L, Ramella S. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2004;128:489-490.
91. Trodella L, Granone P, Valente S, et al. Neoadjuvant concurrent radiochemotherapy in locally advanced (IIIA-IIIB) non-small-cell lung cancer: long-term results according to downstaging. Ann Oncol. 2004;15:389-398.
92. Betticher DC, Rosell R. Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer. Lung Cancer. 2004;46(suppl 2):S23-S32.